KOJIN THERAPEUTICS

kojin-therapeutics-logo

Founded by Stuart Schreiber, Benjamin Cravatt, Stephanie Dougan, and Vasanthi Viswanathan, Kojin is accelerating a drug discovery platform that connects complex cell states to known biochemical processes such as ferroptosis, or iron-dependent cell death, and enables the development of selective therapies for a broad range of hard-to-treat diseases. The companyโ€™s investors include Polaris Partners, Newpath Partners, Cathay Health, Leaps by Bayer, AbbVie Inc., Eventide Asset Management, Alexandria, and the Dana-Farber Cancer Institute venture firm, Binney Street Capital.

#SimilarOrganizations #People #Financial #Event #Website #More

KOJIN THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Health Care Life Science Medical

Founded:
2020-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.kojintx.com

Total Employee:
11+

Status:
Active

Total Funding:
60 M USD

Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

arcellx-logo

Arcellx

Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.

eikon-therapeutics-logo

Eikon Therapeutics

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

gennao-bio-logo

Gennao Bio

Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.

harmony-biosciences-logo

Harmony Biosciences

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

zosano-pharma-logo

Zosano Pharma

Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.


Current Advisors List

stuart-l-schreiber_image

Stuart L. Schreiber Board Member @ Kojin Therapeutics
Board_member

amir-nashat_image

Amir Nashat Board Member @ Kojin Therapeutics
Board_member

lucio-iannone_image

Lucio Iannone Director @ Kojin Therapeutics
Board_member
2019-03-05

thomas-cahill_image

Thomas Cahill Board Member @ Kojin Therapeutics
Board_member

luba-greenwood_image

Luba Greenwood Board Member @ Kojin Therapeutics
Board_member

nagesh-k-mahanthappa_image

Nagesh K. Mahanthappa Board Member @ Kojin Therapeutics
Board_member

Current Employees Featured

luba-greenwood_image

Luba Greenwood
Luba Greenwood Director Board Of Directors @ Kojin Therapeutics
Director Board Of Directors
2021-06-01

luba-greenwood_image

Luba Greenwood
Luba Greenwood CEO @ Kojin Therapeutics
CEO
2021-09-01

Founder


benjamin-cravatt_image

Benjamin Cravatt

stephanie-dougan_image

Stephanie Dougan

stuart-l-schreiber_image

Stuart L. Schreiber

vasanthi-viswanathan_image

Vasanthi Viswanathan

Investors List

leaps-by-bayer_image

Leaps by Bayer

Leaps by Bayer investment in Series A - Kojin Therapeutics

abbvie_image

AbbVie

AbbVie investment in Series A - Kojin Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series A - Kojin Therapeutics

alexandria-venture_image

Alexandria Venture

Alexandria Venture investment in Series A - Kojin Therapeutics

eventide-asset-management_image

Eventide

Eventide investment in Series A - Kojin Therapeutics

cathaycapital_image

Cathay Capital

Cathay Capital investment in Series A - Kojin Therapeutics

binney-street-capital_image

Binney Street Capital

Binney Street Capital investment in Series A - Kojin Therapeutics

newpath-management-l-p_image

Newpath Management

Newpath Management investment in Series A - Kojin Therapeutics

Key Employee Changes

Date New article
2021-10-14 Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer

Official Site Inspections

http://www.kojintx.com Semrush global rank: 5.69 M Semrush visits lastest month: 1.48 K

  • Host name: 151.101.2.159
  • IP address: 151.101.2.159
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kojin Therapeutics" on Search Engine